Stroke associated with primary membranous nephropathy in a young adult: Case report

Juan Pablo Morales, .

Keywords: cerebral infarction, Stroke, Young adult, Nephrotic Syndrome, glomerulonephritis, membranous

Abstract

Introduction. Stroke in young individuals is becoming increasingly prevalent worldwide. Its causes can vary widely, so a thorough investigation by a multidisciplinary team is needed. Pinpointing the precise underlying pathology responsible for the stroke yields benefits for patients, particularly in recurrent events.
Case presentation. A 38-year-old man presented to the emergency department with symptoms suggestive of stroke, including right hemiparesis, dysarthria, ataxic gait, and right central facial palsy. The brain magnetic resonance image revealed an ischemic lesion located in the left basal ganglia and near the corona radiata. Following an extensive workup, a diagnosis of nephrotic was reached. Histopathology and the exclusion of secondary causes confirmed primary membranous nephropathy as the underlying condition.
The patient underwent treatment tailored to address the specific glomerulopathy, along with anticoagulation therapy and immunosuppression as per current guidelines. Subsequent assessments showed stabilization of renal function, resolution of the edema, and the absence of new thromboembolic events during follow-up.
Conclusion. The nephrotic syndrome should be recognized as a potential underlying cause of stroke in young patients and, therefore, it should be included in the differential diagnosis during the evaluation of patients with coagulopathies. Nephrotic syndrome screening may be done by conducting a simple urinalysis readily available in most healthcare facilities.
This underlines the importance of considering renal pathology in the assessment of stroke etiologies, especially when coagulation abnormalities are present.

Downloads

Download data is not yet available.
  • Juan Pablo Morales Departamento de Medicina Interna, Universidad del Valle, Cali, Colombia; Hospital Universitario del Valle Evaristo García, Cali, Colombia https://orcid.org/0000-0002-0706-0060

References

Ekker MS, Boot EM, Singhal AB, Tan KS, Debette S, Tuladhar AM, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17:790-801. https://doi.org/10.1016/S1474-4422(18)30233-3

Boot E, Ekker MS, Putaala J, Kittner S, De Leeuw F-E, Tuladhar AM. Ischaemic stroke in young adults: A global perspective. J Neurol Neurosurg Psychiatry. 2020;91:411-7. https://doi.org/10.1136/jnnp-2019-322424

Stack CA, Cole JW. A diagnostic approach to stroke in young adults. Curr Treat Options Cardiovasc Med. 2017;19:1-19. https://doi.org/10.1007/s11936-017-0587-6

Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. https://doi.org/10.1161/01.STR.24.1.35

Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome –associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;73:513-20. https://doi.org/10.2215/CJN.10131011

Zou H, Li Y, Xu G. Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy. BMC Nephrol. 2019;20:1-11. https://doi.org/10.1186/s12882-019-1637-y

Francis JM, Beck Jr LH, Salant DJ. Membranous nephropathy: A journey from bench to bedside. Am J Kidney Dis. 2016;68:138-47. https://doi.org/10.1053/j.ajkd.2016.01.030

Alsharhan L, Beck Jr LH. Membranous nephropathy: Core Curriculum 2021. Am J Kidney Dis. 2021. https://doi.org/10.1053/j.ajkd.2020.10.009

Beck Jr LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21. https://doi.org/10.1056/NEJMoa0810457

Fahal IH, McClelland P, Hay C, Bell G. Arterial thrombosis in the nephrotic syndrome. Postgrad Med J. 1994;70:905-9. https://doi.org/10.1136/pgmj.70.830.905

Lee T, Derebail VK, Kshirsagar AV, Chung Y, Fine JP, Mahoney S, et al. Patients with primary membranous nephropathy are at high risk of cardiovascular events. Kidney Int. 2016;89:1111-8. https://doi.org/10.1016/j.kint.2015.12.041

Roy C, Deschaintre Y, Sabbagh R, Roy D, Cardinal H, Bollée G. Ischemic stroke of possible embolic etiology associated with nephrotic syndrome. Kidney Int Rep. 2017;2:988-94. https://doi.org/10.1016/j.ekir.2017.04.004

Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol. 1998;9:444-50. https://doi.org/10.1681/ASN.V93444

Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019;381:36-46. https://doi.org/10.1056/NEJMoa1814427

Luzardo L, Ottati G, Cabrera J, Trujillo H, Garau M, Bedat CG, et al. Substitution of oral for intravenous cyclophosphamide in membranous nephropathy. Kidney360. 2020;1:943-9. https://doi.org/10.34067/KID.0002802020

How to Cite
1.
Morales JP. Stroke associated with primary membranous nephropathy in a young adult: Case report. biomedica [Internet]. 2024 May 31 [cited 2024 Jul. 22];44(Sp. 1):11-7. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/7117

Some similar items:

Published
2024-05-31

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code